Zura Bio Limited (ZURA) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Zura Bio Limited, updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$4.35
+1.87% today
Market cap
$409M
Overall quality
—
Kronos AI 30-day
+2.4%
4 of 8 simulated paths end higher
Zura Bio Limited (ZURA) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $409M. It trades at $4.35, up 1.87% today. 4 analysts' average target of $19.75 implies +354.0% from today's price. Kronos AI's 30-day forecast is +2.4% (4 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $19.75 |
| Low – high | $11.00 – $26.00 |
| Analysts | 4 |
| Upside to average | +354.0% |
Kronos AI 30-day forecast
| Expected close | $4.37 (+2.4%) |
| Likely range | −9.5% … +7.6% |
| As of | 2026-10-27 |
4 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.